142P Updated results from a phase I, open-label, multicenter, first-in-human study of AMG 404, a checkpoint inhibitor, in patients with advanced solid tumors

Autor:	T.J. Price, H. Prenen, I. Lugowska, G.S. Falchook, J.G. Monzon, H.T. Arkenau, S.P. Chawla, M.N. Hui, Y. Kuboki, R. Dziadziuszko, Y. Ozawa, M.E. Elez Fernandez, C.S.P. Rocha Lima, V. Subbiah, D.S.W. Tan, K. Wang, A. Hindoyan, W. Shi, M. Kistler, N. Hashemi Sadraei
Rok vydání:	2021
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 32:S1440-S1442
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f4b270b7808e72561b5fde10a7089736 https://doi.org/10.1016/j.annonc.2021.10.161 Zobrazit plný text záznamu